Skip to main content
. 2015 Sep 10;83(10):3793–3799. doi: 10.1128/IAI.00531-15

TABLE 1.

Baseline characteristics

Characteristic No. of patients % male Agee (yr) Hemoglobine (g/dl) HRP-2e (AU) Creatininee (mg/dl) ALTe (IU/liter) GCSe
MM 57 78.9 29 (22–39) 10.8 (9.6–12.6) 9.8 (1.1–20.6) 1.3 (1.0–1.5) 39.0 (28.7–51.0) 15
Severe malaria 180 82.2 29 (22–45) 10.0 (8.0–11.4) 22.8 (8.0–40.8)*** 2.2 (1.2–5.4) 58.0 (39.0–85.0) 11
    CMa 48 81.3 28 (20–40) 10.2 (8.7–11.9) 22.5 (4.3–40.7)# 1.3 (1.1–1.7) 46.0 (33.3–60.8) 9
    ARFb 23 91.3 30 (25–45) 9.6 (8.0–10.2) 28.1 (10.9–42.6) 7.0 (5.8–9.1) 41.0 (33.3–55.5) 15
    Hepatopathyc 12 75.0 29 (26–40) 10.3 (9.2–11.0) 13.3 (1.6–25.0) 1.0 (0.8–1.2) 131.5 (99.8–189.0) 15
    Systolic shockd 4 50.0 40 (40–46) 12.7 (7.4–13.6) 23.7 (20.2–37.4) 2.3 (1.3–2.7) 60.5 (44.3–70.8) 15
    Other SNCMf 37 73.0 28 (22–40) 9.5 (6.4–12.0) 14.5 (5.1–29.3) 1.2 (0.9–1.6) 53.0 (33.0–72.0) 15
    MOD 14 85.7 27 (22–53) 10.2 (8.7–11.6) 20.7 (3.0–34.6) 4.3 (3.0–8.6) 136.0 (93.3–160.0) 15
    CM-MOD 42 90.5 35 (23–47) 9.6 (8.0–11.4) 34.1 (20.9–54.2)### 5.4 (3.8–8.1) 68.0 (50.5–104.5) 9
Total 237 76.6 29 (22–41) 10.0 (8.3–12.0) 20.5 (5.6–34.5) 1.6 (1.1–4.2) 52.0 (36.0–79.5) 15
a

CM was diagnosed as a GCS of ≤10.

b

ARF was diagnosed as plasma creatinine levels of >3 mg/dl.

c

Hepatopathy was diagnosed as ALT and AST at >3 times the normal level or as AST at >2 times the normal level and bilirubin levels of >6 mg/dl.

d

Systolic shock was diagnosed as systolic blood pressure of <80 mmHg.

e

Values are medians (interquartile ranges). ***, P ≤ 0.001 for comparison of mild malaria (MM) and severe malaria cases using the Mann-Whitney test. P ≤ 0.05 (#) and P ≤ 0.001 (###) for comparisons of mild malaria cases, patients affected with cerebral malaria (CM), acute renal failure (ARF), hepatopathy, systolic shock, other sever noncerebral malaria cases (SNCM), multiple organ dysfunction (MOD), and CM with MOD (CM-MOD) using the Kruskal-Wallis test with a Dunn's posttest.

f

Jaundice, severe anemia, acidosis, and disseminated intravascular coagulation.